The Phase II multicenter trial investigated the efficacy and safety of eltrombopag in 20 adult Chinese patients with refractory or relapsed severe aplastic anemia.
[Scientific Reports]
Home Newsletters Hematopoiesis News Efficacy and Safety of Eltrombopag in Chinese Patients with Refractory or Relapsed...
